Clinical and bacteriologic efficacy of amoxycillin b.d. (45 mg/kg/day) Versus Amoxycillin t.d.s (40 mg/kg/day) in children with group A β-hemolytic streptococcal tonsillopharyngitis

A. Aguilar, J. C. Tinoco, M. Macias, L. Huicho, J. Levy, H. Trujillo, P. Lopez, M. Pereira, S. Maqbool, Z. A. Bhutta, R. A. Sacy, S. Deacon

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Clinical and bacteriologic efficacy of amoxycillin b.d. (45 mg/kg/day) Versus Amoxycillin t.d.s (40 mg/kg/day) in children with group A β-hemolytic streptococcal tonsillopharyngitis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science